RWD74 Real-World Effectiveness of CDK 4/6 Inhibitor as First-Line Treatment in Patients With HR+, HER2- Advanced Breast Cancer in South Korea - Focused on Underrepresented Younger and Older Age.

Subjects

Subjects :

*CYCLIN-dependent kinases
*METASTATIC breast cancer

Details

Language :

English

ISSN :

10983015

Volume :

25

Issue :

12

Database :

Academic Search Index

Journal :

Value in Health

Publication Type :

Academic Journal

Accession number :

160759762

Full Text :

https://doi.org/10.1016/j.jval.2022.09.2299